The Chinese herbal formula Fuzheng Quxie Decoction attenuates cognitive impairment and protects cerebrovascular function in SAMP8 mice
Received 27 May 2018
Accepted for publication 6 September 2018
Published 9 November 2018 Volume 2018:14 Pages 3037—3051
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Yuping Ning
Feixue Wang,1 Jianchao Feng,2 Yang Yang,1 Jiangang Liu,3 Meixia Liu,1 Zhiyong Wang,1 Hui Pei,1 Yun Wei,1 Hao Li1
1Department of Geriatrics, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China; 2Intensive Care Unit, Heze Hospital of Traditional Chinese Medicine, Heze, Shandong, China; 3Department of Cardiology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China
Purpose: This study was designed to explore the underlying mechanism of action for a Fuzheng Quxie Decoction (FQD) in Alzheimer’s disease (AD), to validate its neuroprotective effects, and to provide experimental support for its predicted mechanism of action.
Methods: An integrative approach to network pharmacology was performed to predict the mechanism of action for treatment of AD with FQD. The predicted mechanism was validated in SAMP8 mice.
Results: With predicted putative FQD targets and a collection of AD-related genes, 245 possible regulatory targets of FQD were identified for the treatment of AD. Pathway-enrichment analysis for the possible regulatory targets indicated that vascular endothelial growth factor (VEGF) and VEGF-receptor signaling were pivotal in the treatment of AD with FQD. In vivo experiments confirmed the neuroprotective effect and the predicted mechanism of action for treatment of AD with FQD.
Conclusion: This study contributes to an understanding of the neuroprotective effect of FQD and its potential mechanism of action for the treatment of AD.
Keywords: Alzheimer’s disease, Fuzheng Quxie Decoction, network pharmacology, microcerebrovascular, vascular endothelial growth factor, hypoxia-induced factor 1α
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]